Latest News
From the Journals
24-hour ambulatory BP measurements strongly predict mortality
Masked hypertension identified by 24-hour monitoring carried the greatest risk of death.
News
FDA approves burosumab to treat X-linked hypophosphatemia
Clinical trials showed normalization of phosphorus levels and radiographic improvement.
Daily News Podcast
MDedge Daily News: Which diabetes drug boosts survival best?
And there’s new promise in early-stage lung cancer.
From the Journals
‘Fast food swamps’ linked to type 1 diabetes
Greater concentrations of fast food restaurants in an area have been linked to a higher prevalence of pediatric type 1, but not type 2, diabetes...
From the Journals
VIDEO: Meta-analysis: Mortality, safety data may favor SGLT2 inhibitors in T2DM
GLP-1 agonists were associated with a higher risk of adverse events that led to study withdrawal, compared with SGLT2 inhibitors.
Daily News Podcast
MDedge Daily News: Can a nasal spray reverse suicidality?
And pain relievers and inflammatory bowel disease? It’s complicated.
Daily News Podcast
MDedge Daily News: Shingles boosts stroke risk
And marijuana use may spur change in safety-sensitive industries.
Conference Coverage
Consider spironolactone in treatment-resistant hypertension
ORLANDO – How to apply the lessons of PATHWAY-2 trial to everyday practice.
Daily News Podcast
MDedge Daily News: Where doctors stand on Medicaid work requirements
And asthma is flourishing in a surprising location.
Conference Coverage
Estrogen patch counters eating disorders in women athletes
CHICAGO – When women athletes are proud of training so hard they stop their periods, getting them on estrogen therapy may be a hard sell.
Daily News Podcast
MDedge Daily News: Is rosacea a red flag for deeper dangers?
And why reading aloud to kids can cut hyperactivity.